Fontan Procedure (Fontan Operation)

Subscribe to Selected New Research on Fontan Procedure

659 relevant articles (21 outcomes, 35 trials/studies) found for this Therapy

Description: A procedure in which total right atrial or total caval blood flow is channeled directly into the pulmonary artery or into a small right ventricle that serves only as a conduit. The principal congenital malformations for which this operation is useful are TRICUSPID ATRESIA and single ventricle with pulmonary stenosis.

Also Known As:

Fontan Operation; Hemi Fontan Procedure; Operation, Fontan; Procedure, Fontan; Procedure, Hemi-Fontan; Hemi-Fontan Procedure

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Surgical Anastomosis: 83

Right Heart Bypass: 224

Fontan Procedure: 659

Thoracic Surgical Procedures: 43

Cardiac Surgical Procedures: 203

Right Heart Bypass: 224

Fontan Procedure: 659

Cardiovascular Surgical Procedures: 18

Cardiac Surgical Procedures: 203

Right Heart Bypass: 224

Fontan Procedure: 659

Experts

1.	Cetta, Frank: 4 articles (07/2008 - 01/2003)
2.	Nakanishi, Toshio: 3 articles (08/2008 - 08/2002)
3.	Harada, Yorikazu: 3 articles (04/2008 - 08/2004)
4.	Goldberg, C S: 3 articles (11/2007 - 06/2000)
5.	Bove, E L: 3 articles (11/2007 - 06/2000)
6.	Rychik, Jack: 3 articles (09/2007 - 09/2002)
7.	McMahon, C J: 3 articles (12/2004 - 03/2001)
8.	del Nido, Pedro J: 3 articles (03/2004 - 12/2002)
9.	O'Leary, Patrick W: 2 articles (07/2008 - 12/2006)
10.	Uchita, Shunji: 2 articles (04/2008 - 11/2006)

Related Diseases

1.	Tricuspid Atresia 03/01/2003 - "Our 20-year experience with modified Fontan procedure for tricuspid atresia and various forms of univentricular heart has resulted in improved outcome with most survivors now leading lives of good quality into adulthood." 03/01/1989 - "It was thought that the long-term survival of patients with tricuspid atresia would be improved by the introduction of the Fontan procedure and its subsequent modifications" 09/01/1985 - "The Fontan procedure has afforded improved surgical repair for several complex congenital cardiac defects, including tricuspid atresia and single ventricle" 10/01/1993 - "The purpose of this study was to determine whether wall motion abnormalities are present before or after the Fontan procedure in patients with a univentricular heart of the left ventricular type with an absent right atrioventricular valve connection (tricuspid atresia) and to assess the impact of such abnormalities on ventricular performance and clinical outcome" 09/01/1987 - "The study showed that (1) the modified Fontan procedure can be performed with low in-hospital mortality (12%) in patients with tricuspid atresia and double-inlet ventricle, (2) hospital survivors have an estimated 5 year survival of 87%, (3) subjectively, functional status is good for hospital survivors at intermediate follow-up, and (4) fluid retention continues to be a problem in a minority (16%) of patients." Order ALL the reference details at left...
2.	Heart Diseases (Heart Disease) 02/01/2007 - "The Fontan operation is performed on those with highly complex congenital heart disease and has improved the survival and quality of life of such patients" 11/01/2007 - "Heart transplantation can be successful in patients with end-stage congenital heart diseases after Fontan procedure, because of improved surgical and medical management" 10/01/1991 - "Thus, the modified Fontan operation offers an alternate surgical approach for patients with complex congenital heart disease for whom no other palliative procedure can be expected to obtain significant improvement" 01/01/1992 - "OBJECTIVE--To study the incidence, predisposing factors, and clinical significance of arrhythmias early and late after the Fontan operation for congenital heart disease" 05/01/1990 - "A study was undertaken to determine the early and long-term outcomes dictated by the Fontan state per se (a state in which the force driving pulmonary blood flow is solely or largely a residue, in the systemic venous pressure, of the main ventricular chamber's contractile force) and the transition (by surgery) to it from the state of congenital heart disease under optimal conditions (after a "perfect" Fontan operation)" Order ALL the reference details at left...
3.	Syndrome 09/01/1992 - "Although the mortality rate has improved for patients without this syndrome undergoing the Fontan procedure, it remains high for patients with heterotaxy syndrome" 08/01/1988 - "We conclude: (1) The Fontan operation for patients with asplenia or polysplenia syndromes has resulted in a significant (although recently declining) mortality; (2) mortality is higher in patients with asplenia; (3) patients with atrioventricular valve insufficiency requiring repair or replacement are at higher risk; and (4) intraatrial conduits seem to offer promise for successfully accomplishing this repair." 09/01/1992 - "This study suggests that the outcome of the Fontan procedure in patients with heterotaxy syndrome may be improved by early protection of the pulmonary vascular bed, despite the existence of other cardiac anomalies." 10/01/2006 - "We studied whether the outcome of those patients with heterotaxy syndrome improved compared with those who did not have the syndrome after an extracardiac Fontan operation" 09/01/1992 - "This study was undertaken to determine those factors that may influence survival in patients with heterotaxy syndrome undergoing the Fontan procedure" Order ALL the reference details at left...
4.	Tachycardia (Tachyarrhythmias) 06/01/1993 - "The hypothermic therapy was thought to be effective in acute stage after Fontan operation, because it improved tachycardia, decreased the systemic metabolism, redistributed the systemic arterial blood flow and increased the urinary output." 03/01/2004 - "OBJECTIVES: We evaluated the feasibility, safety, and short-term efficacy of an interventional atrial incision placed at the time of the Fontan operation to reduce the development of intra-atrial reentrant tachycardia" 02/01/2006 - "Mapping and successful ablation of an intra-atrial re-entry tachycardia in a patient after Fontan operation were performed within the anatomy, superimposed from the computed tomography study" 03/01/2004 - "Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial." 02/01/2001 - "OBJECTIVES: The purpose of this study was to compare the clinical and echocardiographic features of adults who developed atrial tachyarrhythmias (ATs) late after a Fontan procedure with those who have remained free of arrhythmias" Order ALL the reference details at left...
5.	Atrial Flutter (Flutter, Atrial) 04/01/1994 - "The purpose of this study was to review the management of atrial flutter occurring after the Fontan procedure" 03/01/2001 - "CONCLUSION: In 1-ventricle hearts, significant atrioventricular valve regurgitation is commonly associated with atrial flutter in patients who did not undergo the Fontan procedure, and with electromechanical disturbances in those who did" 03/01/2001 - "Atrial and ventricular electromechanical function in 1-ventricle hearts: influence of atrial flutter and Fontan procedure." 08/01/2000 - "BACKGROUND: Onset of atrial flutter/fibrillation (AFF) in patients who have undergone Fontan operation for univentricular hearts constitutes an unfavorable clinical event associated with a high risk of cardiovascular complications" 01/01/1998 - "Atrial flutter (AFL) is a common problem in children who have undergone a Fontan operation for single ventricle physiology" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Plastics
2.	Endothelins (Endothelin)
3.	Propafenone (Rythmol)
4.	bosentan (Tracleer)
5.	Oxygen
6.	Blood Coagulation Factors (Coagulation Factor)
7.	pro-brain natriuretic peptide (1-76)
8.	Heparin (Liquaemin)
9.	Brain Natriuretic Peptide (Natrecor)
10.	Prednisone (Sone)

Related Therapies and Procedures

1.	Heart Transplantation (Grafting, Heart)
2.	Stents
3.	Transplants (Transplant)
4.	Cardiopulmonary Bypass (Heart-Lung Bypass)
5.	Hemodilution

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>